China Digest: LTZ Therapeutics, MolBreeding Biotech secure funding

China Digest: LTZ Therapeutics, MolBreeding Biotech secure funding

Photo by RephiLe water on Unsplash

30 July, 2024

Chinese startups MolBreeding Biotech and LTZ Therapeutics have raised funding.

Edited by: Padma Priya

Printed by Unregistered user on Fri, 04 Jul 2025 00:20:26 GMT

and Suzhou International Development Venture Capital (SIDVC); meanwhile Dalton Venture Lake Bleu Capital Starlight Capital Suzhou Capital Group

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Partners Group vies for China’s rich with evergreen funds

China M&A deals down 45% in first half as economic slump continues

Read more from Greater China

Alibaba looking to raise $1.53b via exchangeable bonds for cloud, commerce push

Venture Capital

EACON closes CATL Capital-led Series D round and 48 deals worth over $980m